Finzati - Logo
GTBIF logo

Green Thumb Industries Inc.

GTBIFDrug Manufacturers - Specialty & Generic
$7.69
+0.19 (+2.53%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$1.71B
Growth
Cash Flow
3/5
Trend
Mostly stable
Evidence
Positive revenue growth · 5.8%Positive free cash flow · 0.91Reasonable earnings multiple · 16.19Manageable debt level · 0.27Healthy liquidity · 1.55
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:57 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$7.69
Change2.53%
Shares Out222.78M
Market Cap$1.71B
Enterprise Value$1.99B
52W Range5.29 - 10.43
Beta0.92
P/E13.43
P/S1.42
P/B0.92
P/FCF8.66
EV/Sales1.65

Investment DNA

How strong this company looks for long-term investors

79
out of 100
Business Quality
Margins, moat, returns
68/100
Financial Strength
Debt, cash, stability
86/100
Growth Potential
Revenue and expansion
85/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score
Positive revenue growth · 5.8%Positive free cash flow · 0.91Reasonable earnings multiple · 16.19Manageable debt level · 0.27Healthy liquidity · 1.55

Analyst view

Analyst sentiment and price target

GTBIF
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
100/100
Bullish
Bullish
5
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$18.00
Mean
$18.00
Median
$18.00
High
$18.00

Company Overview

IPO: 6/14/2018
Industry: Drug Manufacturers - Specialty & Generic
P/B i: 0.92
Debt / Equity i: 0.27
Operating Margin: 11.92%
Net Margin: 9.88%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.27
Current Ratio: 1.55
Quick Ratio: 1.55
Status: Strong

Insider Transactions

Recent executive and insider activity

2 high-volume insider sells detected
Kravitz Bret
Transaction: 01/02/2024
SELL
Change
-3,080
Price
$10.90
Filing
01/03/2024
Type
SELL
FAULKNER Mathew
Transaction: 01/02/2024
SELL
Change
-3,423
Price
$10.90
Filing
01/03/2024
Type
SELL
Berger Wendy Alison
Transaction: 12/01/2023
BUY
Change
+5,362
Price
Not reported
Filing
12/05/2023
Type
BUY